Alumis Inc.(ALMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ALMS Alumis Inc.

Post-Mkt 09-17 16:35:01 EDT

7.82

-0.12

-1.51%

盘后7.84

+0.02+0.26%

16:30 EDT

High8.11	Low7.76	Vol3.51M
Open8.03	D1 Closing7.94	Amplitude4.47%
Mkt Cap1.01B	Tradable Cap759.75M	Total Shares129.00M
T/O27.52M	T/O Rate3.61%	Tradable Shares97.15M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ALMS","market":"US","secType":"STK","nameCN":"Alumis Inc.","latestPrice":7.82,"timestamp":1789675200000,"preClose":7.94,"halted":0,"volume":3508693,"hourTrading":{"tag":"盘后","latestPrice":7.84,"preClose":7.82,"latestTime":"16:30 EDT","volume":32564,"amount":254670.66968,"timestamp":1789677052779,"change":0.02,"changeRate":0.002558,"amplitude":0.003836},"delay":0,"changeRate":-0.015113350125944598,"floatShares":97154700,"shares":129000000,"eps":-3.800544,"marketStatus":"Post-Mkt","change":-0.12,"latestTime":"09-17 16:35:01 EDT","open":8.03,"high":8.11,"low":7.755,"amount":27518430.081797,"amplitude":0.04471,"askPrice":8.1,"askSize":50,"bidPrice":7.82,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-3.800544,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":4,"adr":0,"listingDate":1719547200000,"exchange":"NASDAQ","adjPreClose":7.94,"preHourTrading":{"tag":"盘前","latestPrice":8.03,"preClose":7.94,"latestTime":"09:29 EDT","volume":3688,"amount":29636.015647999997,"timestamp":1789651799999,"change":0.09,"changeRate":0.011335,"amplitude":0.016373},"postHourTrading":{"tag":"盘后","latestPrice":7.84,"preClose":7.82,"latestTime":"16:30 EDT","volume":32564,"amount":254670.66968,"timestamp":1789677052779,"change":0.02,"changeRate":0.002558,"amplitude":0.003836},"volumeRatio":0.835411,"impliedVol":0.968,"impliedVolPercentile":0.4143},"requestUrl":"/m/hq/s/ALMS","defaultTab":"news","newsList":[{"id":"2666560995","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560995","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560995?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:10","pubTimestamp":1789038656,"startTime":"0","endTime":"0","summary":"Aeon Biopharma  shares were up more than 39% in Thursday's premarket activity after the company announced positive data from a pilot forced degradation study for its lead drug candidate, ABP-450.Culp  stock was 19% higher after the company swung to fiscal Q1 earnings and higher revenue.Golden Heaven Group  shares up were more than 15% after a 4.3% rise in the prior session.Vince  stock was 11% higher after the company's Q2 results.Alumis  shares were up more than 6%, swinging from a 7.4% fall at the previous close.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CULP","BK4202","AEON","BK4216","BK4139","BK4010","BK4007","GDHG","ALMS","VNCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559445","title":"Alumis Director Srinivas Akkaraju Reports Disposal of 96,131 Common Shares Worth $1.01 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559445","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559445?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:40","pubTimestamp":1789004425,"startTime":"0","endTime":"0","summary":"Alumis director Srinivas Akkaraju reports disposal of 96,131 common shares worth $1.01 millionDirector Srinivas Akkaraju reported net purchases of Alumis common stock through affiliated funds in early","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbwXXZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alumis Director Srinivas Akkaraju Reports Disposal of 96,131 Common Shares Worth $1.01 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666532362","title":"Wells Fargo Sticks to Its Buy Rating for Alumis Inc. (ALMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666532362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666532362?lang=en_us&edition=fundamental","pubTime":"2026-09-10 01:15","pubTimestamp":1788974122,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Derek Archila maintained a Buy rating on Alumis Inc. today and set a price target of $25.00. Archila covers the Healthcare sect...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wells-fargo-sticks-to-its-buy-rating-for-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wells-fargo-sticks-to-its-buy-rating-for-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664691331","title":"Alumis to Present at Wells Fargo Annual Healthcare Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664691331","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664691331?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:01","pubTimestamp":1788523291,"startTime":"0","endTime":"0","summary":"Alumis to present at Wells Fargo annual healthcare investor conferenceAlumis will join investor conferences in September 2026, including Wells Fargo in Boston on Sept. 8-10.Management is scheduled for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDLbt0W1s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWB","BK4127","LU0225283273.USD","LU1668664300.SGD","ALMS","SG9999014039.USD","BK4534","BCDF","LU2111349929.HKD","LU1720051017.SGD","LU1064131342.USD","LU2347655156.SGD","LU1791710582.SGD","LU1548497426.USD","LU2133065610.SGD","SG9999014013.SGD","SG9999014021.USD","LU0557290698.USD","IE00BKVL7J92.USD","IAI","LU0106261372.USD","IE00BN0W2W23.USD","LU1720051108.HKD","LU1989772840.SGD","LU2210150020.SGD","BK4504","LU1074936037.SGD","LU0795875169.SGD","LU0267386448.USD","SG9999014005.SGD","LU2357305700.SGD","LU0971096721.USD","BK4588","LU2089284900.SGD","LU1244550494.USD","NDAQ","IE00B64PRP62.GBP","LU0320765646.SGD","LU2089283258.USD","IE00BQXX3F31.USD","LU1162221912.USD","LU2028103732.USD","LU2487616109.SGD","LU0158827948.USD","LU0314104364.USD","LU0098860793.USD","LU1244550577.SGD","BK4585","LU0106831901.USD","LU1732800096.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664808827","title":"Analysts’ Top Healthcare Picks: uniQure (QURE), Alumis Inc. (ALMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664808827","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664808827?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:30","pubTimestamp":1788445821,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on uniQure (QURE), Alumis Inc. (ALMS) and Omnicell (OMC...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-uniqure-qure-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-uniqure-qure-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS","BK4581","LU0320765992.SGD","BK4585","BK4007","LU0109394709.USD","QURE","XBI","LU0029874061.USD","LU0889565916.HKD","BK4139","LABU","BK4137","HCSG","BK4588","LU0128526141.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664728877","title":"Alumis Cut to Neutral from Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2664728877","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664728877?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:46","pubTimestamp":1788443160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMS/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664636879","title":"Guggenheim Downgrades Alumis to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664636879","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664636879?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:15","pubTimestamp":1788434106,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) has an average rating of buy and mean price target of $31.44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664873762","title":"Alumis downgraded to Neutral from Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2664873762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664873762?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:40","pubTimestamp":1788428413,"startTime":"0","endTime":"0","summary":"Guggenheim downgraded Alumis (ALMS) to Neutral from Buy without a price target after the Phase IIb study evaluating envudeucitinib in systemic lupu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-downgraded-to-neutral-from-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-downgraded-to-neutral-from-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664730678","title":"Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Alumis Inc. (ALMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664730678","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664730678?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:40","pubTimestamp":1788428406,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Envista Holdings (NVST) and Alumis Inc. (ALMS). En...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-envista-holdings-nvst-and-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-envista-holdings-nvst-and-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","LABU","BK4581","IE00B19Z6F94.USD","LU0648000940.SGD","BK4585","NVST","BK4007","LU0130103400.USD","LU0029874061.USD","HCSG","XBI","XLV","IE0034390439.USD","LU0128526141.USD","LU0477156797.USD","LU1201861165.SGD","ALMS","BK4588","BK4137","LU0130518102.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664311845","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2664311845","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664311845?lang=en_us&edition=fundamental","pubTime":"2026-09-03 01:50","pubTimestamp":1788371420,"startTime":"0","endTime":"0","summary":"Purple Biotech (PPBT) said Wednesday that the US Patent and Trademark Office has issued a \"Notice of Allowance\" for a patent application covering tri-specific antibody constructs and methods of use, f","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PPBT","ALMS","BK4007","LHSW","BK4140"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664884843","title":"Alumis rises 10.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664884843","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664884843?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:05","pubTimestamp":1788365143,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) is up 10.7%, or $1.01 to $10.48. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-rises-10-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-rises-10-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664284869","title":"Alumis' Share Price Fall After Envudeucitinib Trial Data Likely Overreaction, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664284869","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664284869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 23:40","pubTimestamp":1788363637,"startTime":"0","endTime":"0","summary":"Alumis' (ALMS) share price drop after the disappointing results of a phase 2b trial of envudeucitinib to treat systemic lupus erythematosus was likely an overreaction, Oppenheimer said in a note email","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664816199","title":"Alumis Price Target Cut to $15.00/Share from $25.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2664816199","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664816199?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:30","pubTimestamp":1788348600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMS/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664932815","title":"Alumis price target lowered to $29 from $39 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2664932815","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664932815?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:55","pubTimestamp":1788346554,"startTime":"0","endTime":"0","summary":"Morgan Stanley lowered the firm’s price target on Alumis (ALMS) to $29 from $39 and keeps an Overweight rating on the shares. The firm is removing ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-price-target-lowered-to-29-from-39-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-price-target-lowered-to-29-from-39-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664081594","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664081594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664081594?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:50","pubTimestamp":1788346221,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alumis-inc-alms-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alumis-inc-alms-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B894F039.SGD","MDT","LU0265550359.USD","LU0058720904.USD","BK4581","LU2089283258.USD","LU0314106906.USD","LU0106261372.USD","TBXU","LU1093756325.SGD","IE0002141913.USD","LABU","BIB","XLV","LU1778281490.HKD","LU0265550946.USD","HCSG","LU2417539215.USD","VRTX","LU2112291526.USD","LU0234570918.USD","BK4588","IDNA","LU1057294990.SGD","ALMS","LU1506573853.SGD","BK4139","IE00B19Z3B42.SGD","VERX","LU1674673691.USD","IBB","LU2023251221.USD","IE00B3T34201.USD","IE0009355771.USD","SG9999001176.SGD","LU1116320901.HKD","BBH","LU2456880835.USD","XBI","BK4533","LU0158827948.USD","LU1291159041.SGD","IE00B2B36J28.USD","PBE","GNMX","LU0162691827.USD","LU0496365809.HKD","LU1061106388.HKD","IBBQ","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664813711","title":"HC Wainwright Upgrades Alumis to Buy From Neutral, Adjusts Price Target to $15 From $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2664813711","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664813711?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:40","pubTimestamp":1788345647,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) has an average rating of buy and mean price target of $31.44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664136858","title":"Alumis upgraded to Buy from Neutral at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2664136858","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664136858?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:10","pubTimestamp":1788343808,"startTime":"0","endTime":"0","summary":"H.C. Wainwright upgraded Alumis (ALMS) to Buy from Neutral with a price target of $15, down from $25. The firm believes the LUMUS study miss remove...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-upgraded-to-buy-from-neutral-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-upgraded-to-buy-from-neutral-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818036","title":"Alumis Inc. : H.c. Wainwright Cuts to Buy from Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818036","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818036?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:10","pubTimestamp":1788343800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nAZN4THX38:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894271","title":"U.S. Research Roundup-Adobe, Dell Technologies, Zscaler","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894271","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664894271?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:46","pubTimestamp":1788335191,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Adobe, Dell Technologies, ZscalerSept 2 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adobe, Dell ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U0MN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JRE","REA","ZS","OGE","ASO","PL","ERET","GWRE","GTLB","PSR","MDB","ADBE","ORCL","WCLD","WCBR","EIX","WELL","ALMS","KNF","SAIC","DELL","RKLX","VNQ","ASTS","MTRN","ASTX","EYPT","FSPC","ESI","ENOV","IPX.AU","MLM","CIBR","USAR","NB","BRZE","PANW","AMRZ","SPAM","HAWK","MMED","SRE","SUNB","ALM","DOCU","RKLB","DLLL","CRK","TDIV","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664893184","title":"Alumis Inc. : Leerink Partners Cuts Target Price to $26 from $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2664893184","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664893184?lang=en_us&edition=fundamental","pubTime":"2026-09-02 11:37","pubTimestamp":1788320279,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U05P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alumis.com","stockEarnings":[{"period":"1week","weight":-0.1898},{"period":"1month","weight":-0.6886},{"period":"3month","weight":-0.6608},{"period":"6month","weight":-0.6832},{"period":"1year","weight":0.9087},{"period":"ytd","weight":-0.1865}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0241},{"period":"3month","weight":0.0098},{"period":"6month","weight":0.1626},{"period":"1year","weight":0.1425},{"period":"ytd","weight":0.1058}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Alumis Inc. was incorporated on January 29, 2021, as a Delaware corporation. It is a clinical-stage biopharmaceutical company initially focused on developing two tyrosine kinase 2 (TYK2) inhibitors: ESK-001, a second-generation inhibitor designed to achieve maximal target inhibition, and A-005, a CNS-penetrant molecule. The company's mission is to significantly improve patients' lives by replacing broad immunosuppression with targeted therapies.","exchange":"NASDAQ","name":"Alumis Inc.","nameEN":"Alumis Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alumis Inc.(ALMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Alumis Inc.(ALMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Alumis Inc.,ALMS,Alumis Inc.股票,Alumis Inc.股票老虎,Alumis Inc.股票老虎国际,Alumis Inc.行情,Alumis Inc.股票行情,Alumis Inc.股价,Alumis Inc.股市,Alumis Inc.股票价格,Alumis Inc.股票交易,Alumis Inc.股票购买,Alumis Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alumis Inc.(ALMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Alumis Inc.(ALMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction